SCHEMBL6822195

SCHEMBL6822195

CC(=O)CCCC(C)CCCC(C)CCCC(C)CCCC(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BLM P54132 1/20 0.57
▸ LMNA P02545 1/20 0.56
▸ PTPN1 P18031 3/20 0.55
▸ KDM1A O60341 1/20 0.44
▸ MEN1 O00255 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CA1 P00915 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ SNCA P37840 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ PAOX Q6QHF9 1/20 0.38
▸ PTPN2 P17706 1/20 0.37
▸ CDC25B P30305 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944875 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL15825692 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL7943009 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL14249242 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL15824542 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL8908184 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL716506 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL7942967 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL117939 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1
SCHEMBL6822085 1.00 BLM (0.57) BLMLMNAPTPN1KDM1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137756-A1 COMPOUNDS AND METHODS FOR LIQUID PHASE OLIGONUCLEOTIDE SYNTHESIS HONGENE BIOTECH CORPORATION (US) 2024-06-27 — — WO disclosed
CN-116462578-B Method for synthesizing delta-methyl ketone by one-pot method 万华化学集团股份有限公司 2024-04-09 — — CN disclosed
CN-116462578-A Method for synthesizing delta-methyl ketone by one-pot method 万华化学集团股份有限公司 2023-07-21 — — CN disclosed
US-9561989-B2 Process of asymmetric hydrogenation of ketals and acetals DSM IP ASSETS B.V. (NL) 2017-02-07 — — US disclosed
US-20160185683-A1 PROCESS OF ASYMMETRIC HYDROGENATION OF KETALS AND ACETALS DSM IP ASSETS B.V. (NL) 2016-06-30 — — US disclosed
US-20150321971-A1 EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES DSM IP ASSETS B.V. (NL) 2015-11-12 — — US disclosed
EP-1122236-B1 Process for producing 6-methyl-3-hepten-2-one, and process for producing phyton or isophytol KURARAY CO (JP) 2004-09-29 — — EP disclosed
EP-0816321-B1 Process for producing 6-methyl-2-heptanone analogues, and process for producing phyton and isophytol KURARAY CO (JP) 2002-06-05 — — EP disclosed
US-6288128-B1 β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound EISAI CO., LTD. (JP) 2001-09-11 — — US disclosed
EP-1122236-A2 Process for producing 6-methyl-3-hepten-2-one, and process for producing phyton or isophytol Kuraray Co., Ltd., Kurashiki Plant (JP) 2001-08-08 — — EP disclosed
US-6232506-B1 SUBJECTING ISOVALERALDEHYDE AND ACETONE TO CROSS ALDOL CONDENSATION CARRIED OUT WHILE CONTINUOUSLY ADDING TO ACETONE BOTH ISOVALERALDEHYDE AND AQUEOUS ALKALI CONTAINING ALKALINE SUBSTANCE TO GIVE 6-METHYL-3-HEPTEN-2-ONE KURARAY CO., LYD. (JP) 2001-05-15 — — US disclosed
US-6111131-A SUCH AS 3,7,11,15,19,23,27,31-OCTAMETHYL-2,6,10,14,18,22,26,30-DOTRIACONTAOCTAEN-1 -OL; USEFUL AS PROPHYLACTIC DRUG FOR IMMUNODEFICIENCY DISEASES AND INFECTIOUS DISEASES EISAI CO., LTD. (JP) 2000-08-29 — — US disclosed
US-5955636-A CROSS ALDOL CONDENSATION OF BRANCHED ALDEHYDE AND ACETONE; AQUEOUS ALKALI; HYDROGENATION CATALYST KURARAY CO., LTD. (JP) 1999-09-21 — — US disclosed
EP-0816321-A1 Process for producing 6-methyl-3-hepten-2-one and 6-methyl-2-heptanone analogues, and process for producing phyton or isophytol KURARAY CO., LTD. (JP) 1998-01-07 — — EP disclosed
US-5658958-A β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals EISAI CO., LTD. (JP) 1997-08-19 — — US disclosed
US-5280048-A Antiinfection agent EISAI CO., LTD. (JP) 1994-01-18 — — US disclosed
US-4624966-A β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound EISAI CO., LTD. (JP) 1986-11-25 — — US disclosed
US-4169157-A Therapeutic preparations for peptic ulcers comprising aliphatic ketone derivative EISAI CO., LTD. (JP) 1979-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150321971-A1 EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES ADH5, ADH1A, ADH1C BLM 4162/4885LMNA 3902/4885PTPN1 4844/4885
US-20160185683-A1 PROCESS OF ASYMMETRIC HYDROGENATION OF KETALS AND ACETALS KAT5, AKR1D1, AKR1C2 BLM 4344/4885LMNA 4292/4885PTPN1 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback